Bluestar Genomics ’ breakthrough study highlights promising data for multi-cancer detection from a single blood draw

(CG Life) Bluestar Genomics published a new study demonstrating the efficacy of their 5-hydroxymethylcytosine (5hmC) signal detection technology for its use in breast, lung, pancreatic, and prostate cancer.
Source: EurekAlert! - Biology - Category: Biology Source Type: news